Novozymes A/S (CPH:NSIS.B)
399.60
+8.70 (2.23%)
At close: May 1, 2026
Novozymes Balance Sheet
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 275.3 | 280 | 149.7 | 139.68 | 129.51 |
Cash & Short-Term Investments | 275.3 | 280 | 149.7 | 139.68 | 129.51 |
Cash Growth | -1.68% | 87.04% | 7.17% | 7.86% | -18.64% |
Accounts Receivable | 716.5 | 665.6 | 496.7 | 463.46 | 396.46 |
Other Receivables | 204.8 | 203.6 | 92.4 | 120.09 | 113.64 |
Total Trade Receivables | 921.3 | 869.2 | 589.1 | 583.55 | 510.09 |
Inventory | 772.2 | 720.6 | 486.7 | 510.29 | 402.37 |
Other Current Assets | - | 11.6 | 44.5 | - | - |
Total Current Assets | 1,983 | 1,868 | 1,225 | 1,240 | 1,052 |
Net Property, Plant & Equipment | 2,998 | 2,968 | 1,654 | - | 1,370 |
Other Intangible Assets | 4,896 | 4,419 | 343 | - | 403.99 |
Goodwill | 6,193 | 5,605 | 265 | - | 271.66 |
Long-Term Investments | 51.4 | 46.7 | 41.2 | 53 | 18.02 |
Other Long-Term Assets | 242.2 | 275 | 236.4 | 217.78 | 225.39 |
Total Assets | 16,349 | 15,196 | 3,809 | 3,755 | 3,331 |
Accounts Payable | 420.8 | 423.1 | 216.9 | 250.78 | 200.38 |
Accrued Expenses | - | - | - | - | 168.37 |
Short-Term Debt | - | - | - | - | 273 |
Current Portion of Long-Term Debt | 3,005 | 1,797 | 1,044 | 877.28 | - |
Unearned Revenue | 26 | 22.8 | 8.7 | 12.61 | 4.57 |
Other Current Liabilities | 593 | 376 | 24.6 | 43.74 | 82.84 |
Total Current Liabilities | 2,741 | 1,088 | 972.7 | 934.3 | 762.92 |
Long-Term Debt | - | - | - | - | 494.36 |
Long-Term Leases | - | - | - | 55.15 | 64.82 |
Other Long-Term Liabilities | 1,449 | 1,401 | 589.6 | 606.1 | 400.89 |
Total Long-Term Liabilities | 2,753 | 2,931 | 911.1 | 911.36 | 926.32 |
Total Liabilities | 5,494 | 4,020 | 1,884 | 1,846 | 1,689 |
Common Stock | 125.5 | 125.6 | 75.4 | 75.41 | 75.85 |
Accumulated Other Comprehensive Income | - | - | - | - | -5.38 |
Retained Earnings | 10,730 | 11,050 | 1,800 | 1,781 | 1,520 |
Total Common Shareholders' Equity | 10,855 | 11,176 | 1,876 | 1,857 | 1,591 |
Minority Interest | - | - | 50 | 52.46 | 50.97 |
Shareholders' Equity | 10,855 | 11,176 | 1,926 | 1,909 | 1,642 |
Total Liabilities & Equity | 16,349 | 15,196 | 3,809 | 3,755 | 3,331 |
Total Debt | 3,005 | 1,797 | 1,044 | 932.42 | 832.18 |
Net Cash (Debt) | -2,730 | -1,517 | -894.3 | -792.74 | -702.67 |
Net Cash Per Share | -5.84 | -3.30 | -3.22 | -2.84 | -2.51 |
Book Value | 10,855 | 11,176 | 1,876 | 1,857 | 1,591 |
Book Value Per Share | 23.22 | 24.32 | 6.75 | 6.66 | 5.68 |
Tangible Book Value | -233.2 | 1,152 | 1,268 | 1,857 | 914.89 |
Tangible Book Value Per Share | -0.50 | 2.51 | 4.56 | 6.66 | 3.27 |
Updated Dec 31, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.